AAPL289.16+7.42 (+2.63%) ▲|ABBV252.55-1.76 (-0.69%) ▼|ABT91.62-1.09 (-1.18%) ▼|ACN123.89-0.85 (-0.68%) ▼|ADBE202.40-4.04 (-1.95%) ▼|AMAT730.21+35.57 (+5.12%) ▲|AMD572.95+33.46 (+6.20%) ▲|AMGN359.32-1.23 (-0.34%) ▼|AMT164.00-4.67 (-2.77%) ▼|AMZN239.47-0.67 (-0.28%) ▼|AVGO375.32+2.87 (+0.77%) ▲|AXP337.93-2.95 (-0.87%) ▼|BA216.73+2.04 (+0.95%) ▲|BAC57.02-0.87 (-1.49%) ▼|BKNG179.97-2.44 (-1.34%) ▼|BLK961.93+11.76 (+1.24%) ▲|BMY57.76-0.81 (-1.37%) ▼|BNY144.96+1.16 (+0.81%) ▲|BRK-B496.56+0.56 (+0.11%) ▲|C140.00-2.49 (-1.75%) ▼|CAT1,063.07+29.88 (+2.89%) ▲|CL91.95-0.46 (-0.49%) ▼|CMCSA24.54+0.32 (+1.30%) ▲|COF200.47-1.81 (-0.89%) ▼|COP104.36+0.16 (+0.15%) ▲|COST936.72-9.96 (-1.05%) ▼|CRM154.85-3.08 (-1.95%) ▼|CSCO118.13+0.43 (+0.36%) ▲|CVS103.39-0.20 (-0.19%) ▼|CVX167.77-0.70 (-0.42%) ▼|DE627.71+2.70 (+0.43%) ▲|DHR190.17-2.61 (-1.35%) ▼|DIS96.82-1.07 (-1.09%) ▼|DUK127.75-0.58 (-0.45%) ▼|EMR143.17+0.35 (+0.25%) ▲|FDX310.30-15.10 (-4.64%) ▼|GD352.36+4.29 (+1.23%) ▲|GE372.14-1.57 (-0.42%) ▼|GEV1,136.11+33.60 (+3.05%) ▲|GILD125.94-0.40 (-0.31%) ▼|GM76.24-1.10 (-1.42%) ▼|GOOG353.23+1.95 (+0.56%) ▲|GOOGL356.25+2.60 (+0.74%) ▲|GS1,012.12-8.09 (-0.79%) ▼|HD351.68+0.87 (+0.25%) ▲|HON223.56-4.24 (-1.86%) ▼|IBM277.94-0.06 (-0.02%) ▼|INTC139.67+7.95 (+6.04%) ▲|INTU261.85-4.55 (-1.71%) ▼|ISRG402.03-3.94 (-0.97%) ▼|JNJ255.29-3.23 (-1.25%) ▼|JPM327.51-1.88 (-0.57%) ▼|KO82.02-0.63 (-0.76%) ▼|LIN519.52+8.46 (+1.65%) ▲|LLY1,209.02-20.91 (-1.70%) ▼|LMT505.63+3.56 (+0.71%) ▲|LOW219.21-0.44 (-0.20%) ▼|LRCX426.47+15.56 (+3.79%) ▲|MA511.55+1.91 (+0.37%) ▲|MCD269.20+2.02 (+0.76%) ▲|MDLZ58.98-1.17 (-1.95%) ▼|MDT79.32-1.62 (-2.00%) ▼|META556.23-6.37 (-1.13%) ▼|MMM162.36-0.08 (-0.05%) ▼|MO72.57-1.48 (-2.00%) ▼|MRK128.35-1.03 (-0.80%) ▼|MS209.12-2.60 (-1.23%) ▼|MSFT370.29+1.72 (+0.47%) ▲|MU1,143.41-1.88 (-0.16%) ▼|NEE88.15-0.51 (-0.58%) ▼|NFLX72.68-1.11 (-1.50%) ▼|NKE41.04-0.45 (-1.07%) ▼|NOW97.61-2.37 (-2.37%) ▼|NVDA198.38+3.41 (+1.75%) ▲|ORCL145.41-2.36 (-1.59%) ▼|PEP136.34-2.34 (-1.69%) ▼|PFE24.08-0.29 (-1.19%) ▼|PG145.79-2.67 (-1.80%) ▼|PLTR116.87+1.17 (+1.01%) ▲|PM179.75-3.13 (-1.71%) ▼|QCOM186.61-2.11 (-1.12%) ▼|RTX188.55+1.22 (+0.65%) ▲|SBUX102.88-1.18 (-1.13%) ▼|SCHW92.47+1.92 (+2.12%) ▲|SO96.40-0.36 (-0.37%) ▼|SPG224.92-2.65 (-1.16%) ▼|T20.90-0.93 (-4.24%) ▼|TMO500.05-6.37 (-1.26%) ▼|TMUS168.85-5.12 (-2.94%) ▼|TSLA416.37+4.53 (+1.10%) ▲|TXN294.38+8.90 (+3.12%) ▲|UBER73.38-2.12 (-2.81%) ▼|UNH416.48-3.34 (-0.80%) ▼|UNP271.91-0.80 (-0.29%) ▼|UPS106.37-1.64 (-1.52%) ▼|USB60.54-0.22 (-0.36%) ▼|V342.68+1.03 (+0.30%) ▲|VZ42.78-1.32 (-2.99%) ▼|WFC82.82-0.69 (-0.83%) ▼|WMT113.63-0.98 (-0.85%) ▼|XOM136.10+0.04 (+0.03%) ▲|AAPL289.16+7.42 (+2.63%) ▲|ABBV252.55-1.76 (-0.69%) ▼|ABT91.62-1.09 (-1.18%) ▼|ACN123.89-0.85 (-0.68%) ▼|ADBE202.40-4.04 (-1.95%) ▼|AMAT730.21+35.57 (+5.12%) ▲|AMD572.95+33.46 (+6.20%) ▲|AMGN359.32-1.23 (-0.34%) ▼|AMT164.00-4.67 (-2.77%) ▼|AMZN239.47-0.67 (-0.28%) ▼|AVGO375.32+2.87 (+0.77%) ▲|AXP337.93-2.95 (-0.87%) ▼|BA216.73+2.04 (+0.95%) ▲|BAC57.02-0.87 (-1.49%) ▼|BKNG179.97-2.44 (-1.34%) ▼|BLK961.93+11.76 (+1.24%) ▲|BMY57.76-0.81 (-1.37%) ▼|BNY144.96+1.16 (+0.81%) ▲|BRK-B496.56+0.56 (+0.11%) ▲|C140.00-2.49 (-1.75%) ▼|CAT1,063.07+29.88 (+2.89%) ▲|CL91.95-0.46 (-0.49%) ▼|CMCSA24.54+0.32 (+1.30%) ▲|COF200.47-1.81 (-0.89%) ▼|COP104.36+0.16 (+0.15%) ▲|COST936.72-9.96 (-1.05%) ▼|CRM154.85-3.08 (-1.95%) ▼|CSCO118.13+0.43 (+0.36%) ▲|CVS103.39-0.20 (-0.19%) ▼|CVX167.77-0.70 (-0.42%) ▼|DE627.71+2.70 (+0.43%) ▲|DHR190.17-2.61 (-1.35%) ▼|DIS96.82-1.07 (-1.09%) ▼|DUK127.75-0.58 (-0.45%) ▼|EMR143.17+0.35 (+0.25%) ▲|FDX310.30-15.10 (-4.64%) ▼|GD352.36+4.29 (+1.23%) ▲|GE372.14-1.57 (-0.42%) ▼|GEV1,136.11+33.60 (+3.05%) ▲|GILD125.94-0.40 (-0.31%) ▼|GM76.24-1.10 (-1.42%) ▼|GOOG353.23+1.95 (+0.56%) ▲|GOOGL356.25+2.60 (+0.74%) ▲|GS1,012.12-8.09 (-0.79%) ▼|HD351.68+0.87 (+0.25%) ▲|HON223.56-4.24 (-1.86%) ▼|IBM277.94-0.06 (-0.02%) ▼|INTC139.67+7.95 (+6.04%) ▲|INTU261.85-4.55 (-1.71%) ▼|ISRG402.03-3.94 (-0.97%) ▼|JNJ255.29-3.23 (-1.25%) ▼|JPM327.51-1.88 (-0.57%) ▼|KO82.02-0.63 (-0.76%) ▼|LIN519.52+8.46 (+1.65%) ▲|LLY1,209.02-20.91 (-1.70%) ▼|LMT505.63+3.56 (+0.71%) ▲|LOW219.21-0.44 (-0.20%) ▼|LRCX426.47+15.56 (+3.79%) ▲|MA511.55+1.91 (+0.37%) ▲|MCD269.20+2.02 (+0.76%) ▲|MDLZ58.98-1.17 (-1.95%) ▼|MDT79.32-1.62 (-2.00%) ▼|META556.23-6.37 (-1.13%) ▼|MMM162.36-0.08 (-0.05%) ▼|MO72.57-1.48 (-2.00%) ▼|MRK128.35-1.03 (-0.80%) ▼|MS209.12-2.60 (-1.23%) ▼|MSFT370.29+1.72 (+0.47%) ▲|MU1,143.41-1.88 (-0.16%) ▼|NEE88.15-0.51 (-0.58%) ▼|NFLX72.68-1.11 (-1.50%) ▼|NKE41.04-0.45 (-1.07%) ▼|NOW97.61-2.37 (-2.37%) ▼|NVDA198.38+3.41 (+1.75%) ▲|ORCL145.41-2.36 (-1.59%) ▼|PEP136.34-2.34 (-1.69%) ▼|PFE24.08-0.29 (-1.19%) ▼|PG145.79-2.67 (-1.80%) ▼|PLTR116.87+1.17 (+1.01%) ▲|PM179.75-3.13 (-1.71%) ▼|QCOM186.61-2.11 (-1.12%) ▼|RTX188.55+1.22 (+0.65%) ▲|SBUX102.88-1.18 (-1.13%) ▼|SCHW92.47+1.92 (+2.12%) ▲|SO96.40-0.36 (-0.37%) ▼|SPG224.92-2.65 (-1.16%) ▼|T20.90-0.93 (-4.24%) ▼|TMO500.05-6.37 (-1.26%) ▼|TMUS168.85-5.12 (-2.94%) ▼|TSLA416.37+4.53 (+1.10%) ▲|TXN294.38+8.90 (+3.12%) ▲|UBER73.38-2.12 (-2.81%) ▼|UNH416.48-3.34 (-0.80%) ▼|UNP271.91-0.80 (-0.29%) ▼|UPS106.37-1.64 (-1.52%) ▼|USB60.54-0.22 (-0.36%) ▼|V342.68+1.03 (+0.30%) ▲|VZ42.78-1.32 (-2.99%) ▼|WFC82.82-0.69 (-0.83%) ▼|WMT113.63-0.98 (-0.85%) ▼|XOM136.10+0.04 (+0.03%) ▲|

28.8 C

New York

Tuesday, June 30, 2026

Group 1 Automotive Continues Nationwide Brand Alignment with Group 1 Honda South San Antonio in south San Antonio

Bluprynt and Chainproof Launch ‘Verified D&O’ Insurance for the Digital Asset Economy

Profound Launches the Profound Index at Zero Click New York, Creating the Definitive Benchmark for AI Search Visibility

Tag: directors

BAFFIN AND BRUCE TRAIL CONSERVANCY CELEBRATE COMPLETION OF TRAIL CONSERVANCY PROJECT

ONE HUNDRED BOOT BRUSH STATIONS BUILT TO PROTECT AGAINST INVASIVE SPECIES STONEY CREEK, ON, June 23, 2025 /PRNewswire/ - Canadian footwear brand Baffin is proud...

Kiwetinohk announces formal business strategy review

CALGARY, AB, June 23, 2025 /CNW/ - Kiwetinohk Energy Corp. (TSX: KEC) ("Kiwetinohk" or the "Company") announces that it has launched a formal business strategy...

Cango Inc. Announces Fourth Amendment to Share-Settled Crypto Mining Assets Acquisitions

HONG KONG, June 23, 2025 /PRNewswire/ -- Cango Inc. (NYSE: CANG) ("Cango" or the "Company") today announced that it has entered into the fourth...

BAFFIN AND BRUCE TRAIL CONSERVANCY CELEBRATE COMPLETION OF TRAIL CONSERVANCY PROJECT

ONE HUNDRED BOOT BRUSH STATIONS BUILT TO PROTECT AGAINST INVASIVE SPECIES STONEY CREEK, ON, June 23, 2025 /CNW/ - Canadian footwear brand Baffin is proud...

European Medicines Agency Recommends Market Approval of AVT06, Alvotech’s Proposed Biosimilar to Eylea® (aflibercept)

REYKJAVIK, Iceland and LONDON, June 23, 2025 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide and Advanz Pharma, a UK headquartered global pharmaceutical company with a strategic focus on specialty, hospital, and rare disease medicines in Europe, today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human use (CHMP) adopted a positive opinion recommending approval for AVT06, Alvotech’s proposed biosimilar to Eylea® (aflibercept 2 mg). Based on a positive recommendation by CHMP, biosimilar medicines can be approved by the European Commission for marketing in the European Economic Area, that includes the 27 member states of the European Union, in addition to Norway, Iceland and Lichtenstein.

European Medicines Agency Recommends Market Approval of AVT06, Alvotech’s Proposed Biosimilar to Eylea® (aflibercept)

REYKJAVIK, ICELAND and LONDON, UK (June 23, 2025) — Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide and Advanz Pharma, a UK headquartered global pharmaceutical company with a strategic focus on specialty, hospital, and rare disease medicines in Europe, today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human use (CHMP) adopted a positive opinion recommending approval for AVT06, Alvotech’s proposed biosimilar to Eylea® (aflibercept 2 mg). Based on a positive recommendation by CHMP, biosimilar medicines can be approved by the European Commission for marketing in the European Economic Area, that includes the 27 member states of the European Union, in addition to Norway, Iceland and Lichtenstein.

Navamedic ASA expands into addiction treatment through the acquisition of the business of dne pharma and announces a partially underwritten rights issue

NOT FOR DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, CANADA, AUSTRALIA, THE HONG KONG SPECIAL ADMINISTRATIVE REGION OF THE...

Galapagos Appoints Aaron Cox as Chief Financial Officer

Former Horizon CFO joins Galapagos with deep expertise in international corporate finance, M&A, business development and strategic leadership

Kinterra Capital Submits Proposal to Acquire 100% of New World Resources

TORONTO and PERTH, Australia, June 23, 2025 /PRNewswire/ -- Kinterra Capital GP Corp. II ("Kinterra"), in its capacity as general partner of the Kinterra...

Everest Medicines Announces Official Publication of the Specifications for Antimicrobial Susceptibility Testing of Eravacycline (2025)

SHANGHAI, June 23, 2025 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the discovery, clinical development, manufacturing,...

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Broadmark Realty Capital Inc. of Class Action Lawsuit and Upcoming Deadlines...

NEW YORK, June 22, 2025 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Broadmark Realty Capital Inc. ("Broadmark"...

- A word from our sponsors -

Newsletter Signup

Name(Required)

First Last

Company Name

Email(Required)

Enter Email Confirm Email

CAPTCHA

Privacy(Required)

I agree with the storage and handling of my data by this website. - Privacy Policy *

This field is for validation purposes and should be left unchanged.

HomeTagsDirectors

Group 1 Automotive Continues Nationwide Brand Alignment with Group 1 Honda South San Antonio in south San Antonio

Bluprynt and Chainproof Launch ‘Verified D&O’ Insurance for the Digital Asset Economy

Profound Launches the Profound Index at Zero Click New York, Creating the Definitive Benchmark for AI Search Visibility

Tag: directors

BAFFIN AND BRUCE TRAIL CONSERVANCY CELEBRATE COMPLETION OF TRAIL CONSERVANCY PROJECT

Kiwetinohk announces formal business strategy review

Cango Inc. Announces Fourth Amendment to Share-Settled Crypto Mining Assets Acquisitions

BAFFIN AND BRUCE TRAIL CONSERVANCY CELEBRATE COMPLETION OF TRAIL CONSERVANCY PROJECT

European Medicines Agency Recommends Market Approval of AVT06, Alvotech’s Proposed Biosimilar to Eylea® (aflibercept)

European Medicines Agency Recommends Market Approval of AVT06, Alvotech’s Proposed Biosimilar to Eylea® (aflibercept)

Navamedic ASA expands into addiction treatment through the acquisition of the business of dne pharma and announces a partially underwritten rights issue

Galapagos Appoints Aaron Cox as Chief Financial Officer

Kinterra Capital Submits Proposal to Acquire 100% of New World Resources

Everest Medicines Announces Official Publication of the Specifications for Antimicrobial Susceptibility Testing of Eravacycline (2025)

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Broadmark Realty Capital Inc. of Class Action Lawsuit and Upcoming Deadlines...

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of 3D Systems Corporation – DDD

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sable Offshore Corp. – SOC

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PTC Therapeutics, Inc. – PTCT

Newsletter Signup

Explore

Press Releases

News & Opinion

Living

Others

Follow us